View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
July 23, 2015

Pharma Technology Focus – Issue 37

In this issue: New findings on fake medicines, progress in predicting cancer, the rocky road ahead for biosimilars developers, a new wave of treatments for hearing loss, trends in packaging and more.

By Susanne Hauner

Pharma Technology Focus Issue 37

Pharma Technology Focus is now published monthly and free for the iPad. Download our app to read the latest issue and browse our back issues for free.

New data shows that we know nowhere near enough about the true scope of falsified medicines, which pose an urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis. We review the latest research into the issue and ask what the industry can do about it.

A new breakthrough in telomere research could raise the prospect of a cancer-predicting blood test. We find out how the discovery of a vital long-term telomere pattern could affect cancer diagnostics and whether there could be unintended implications for health insurance.

We also take a look at a range of new hearing loss treatments set to come to market, explore the potential of biosimilars in offering cheaper alternatives to some of the most expensive drugs on the market and the regulatory hurdles that need to be overcome, and find out what’s new in pharmaceutical packaging.

Read the issue for free on your iPad through our app, or if you’re on a desktop computer you can also read it in our web viewer.

In this issue

Tip of the IcebergNew data shows that we know nowhere near enough about the true scope of the falsified medicines problem. Elly Earls finds out what the industry can do to gain more data and act upon it.Read the article.

Safe, Simple & SecureFrom new anti-tamper systems and child-proof opening mechanisms to smart tracking technologies, Abi Millar profiles innovations in pharma packaging and the requirements driving them.Read the article.

Eyes on Novartis Novartis stands accused of trying to sabotage research into a rival eye drug in the UK and faces suspension in Japan after a series of trial data scandals. Julian Turner asks GlobalData analyst Shaan Thakerar for his take on the controversy.Read the article.

The Telling TelomereA new breakthrough in telomere research could raise the prospect of a cancer-predicting blood test. Chris Lo finds out how the discovery of a vital long-term telomere pattern could affect cancer diagnostics and whether there would be unintended implications for health insurance.Read the article.

A Rocky Road AheadBiosimilars could save patients and health systems billions, but regulatory and market obstacles stand in the way of this promising field achieving its potential. Chris Lo finds out more.Read the article.

Listen UpHearing loss and tinnitus affect millions of people, but until recently there were no drug treatments being developed for either condition. Elly Earls finds out why things are changing.Read the article.

Next issue preview

South Africa is looking to follow China’s lead by building state-owned pharma manufacturing capacity to help meet the needs of its health system with less reliance on foreign imports, but it has a bumpy road ahead. We find out how the country aims to reach its goal.

We also investigate the details of Teva’s Mylan takeover bid and what it could mean for the generics market, check in on the progress of the US 21st Century Cures Act through the legislative process, and speak to Clinigen about carving out a niche in the ethical supply of unlicensed medicines.

Moreover, we ask why the pharma industry is showing a growing interest in the potential of gamification – an approach that turns taking medicine into a game-like experience though the use of smartphone apps, and hear from IAOCR why CROs need to rethink their recruitment strategies as demand for resources in clinical research grows.

Digital magazine FAQ

You can read Pharma Technology Focus for free on the iPad. Download our app from the App Store to read the latest issue and browse the back issues in our archive. Sign up for a free subscription in the app and never miss a new issue.

You can also continue to read the desktop version for free on our web viewer. (Browser compatibility: The web viewer works in the latest two version of Chrome, Firefox and Safari, as well as in Internet Explorer 9 and 10. Some features may not be compatible with older browser versions.)

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology